101 related articles for article (PubMed ID: 7015991)
1. [Simultaneous determination of blood insulin and plasma C-peptide levels. Value during assessment of glucose tolerance, especially in obese subjects (author's transl)].
Pinget M; Demangeat C; Comte F; Brogard JM; Jacques C; Sapin R; Dorner M
Ann Endocrinol (Paris); 1980; 41(5):399-414. PubMed ID: 7015991
[TBL] [Abstract][Full Text] [Related]
2. Decreased insulin removal contributes to hyperinsulinemia in obesity.
Faber OK; Christensen K; Kehlet H; Madsbad S; Binder C
J Clin Endocrinol Metab; 1981 Sep; 53(3):618-21. PubMed ID: 7021583
[TBL] [Abstract][Full Text] [Related]
3. Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance.
Robertson DA; Singh BM; Nattrass M
Int J Obes; 1991 Oct; 15(10):635-45. PubMed ID: 1752724
[TBL] [Abstract][Full Text] [Related]
4. [Insulin metabolism in obese children tested by oral and intravenous glucose loading].
Blatniczky L; Halász Z
Orv Hetil; 1989 Oct; 130(44):2357-61. PubMed ID: 2682447
[TBL] [Abstract][Full Text] [Related]
5. Decreased plasma C-peptide to insulin molar ratio after oral glucose in elderly subjects.
Ikeda T; Fujiyama K; Takeuchi T; Honda M; Mokuda O; Tominaga M; Mashiba H
Exp Clin Endocrinol; 1989; 94(3):351-6. PubMed ID: 2698354
[TBL] [Abstract][Full Text] [Related]
6. Peripheral hyperinsulinemia of simple obesity: pancreatic hypersecretion or impaired insulin metabolism?
Bonora E; Zavaroni I; Bruschi F; Alpi O; Pezzarossa A; Guerra L; Dall'Aglio E; Coscelli C; Butturini U
J Clin Endocrinol Metab; 1984 Dec; 59(6):1121-7. PubMed ID: 6386838
[TBL] [Abstract][Full Text] [Related]
7. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
Al-Waili N
Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
[TBL] [Abstract][Full Text] [Related]
8. [Behavior of C-peptide and immunoreactive insulin in essential obesity].
Gragnoli G; Signorini AM; Tanganelli I; Martinelli G
Boll Soc Ital Biol Sper; 1979 Mar; 55(6):564-70. PubMed ID: 399187
[TBL] [Abstract][Full Text] [Related]
9. Zinc status in plasma of obese individuals during glucose administration.
Chen MD; Lin PY; Sheu WH
Biol Trace Elem Res; 1997; 60(1-2):123-9. PubMed ID: 9404681
[TBL] [Abstract][Full Text] [Related]
10. Insulin and C-peptide secretion in non-obese patients with polycystic ovarian disease.
Mahabeer S; Jialal I; Norman RJ; Naidoo C; Reddi K; Joubert SM
Horm Metab Res; 1989 Sep; 21(9):502-6. PubMed ID: 2684835
[TBL] [Abstract][Full Text] [Related]
11. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
Calanna S; Piro S; Di Pino A; Maria Zagami R; Urbano F; Purrello F; Maria Rabuazzo A
Obesity (Silver Spring); 2013 Feb; 21(2):320-5. PubMed ID: 23404781
[TBL] [Abstract][Full Text] [Related]
12. [Plasma insulin changes in obesity with or without abnormal glucose tolerance].
García Pascual IJ; González Ruiz JM
An Med Interna; 1993 Oct; 10(10):473-8. PubMed ID: 8136423
[TBL] [Abstract][Full Text] [Related]
13. The molar ratio of C-peptide to insulin after two consecutive stimulations with glucagon in obesity.
Vannini P; Ciavarella A; Flammini M; Forlani G; Capelli M; Cocchi V
Int J Obes; 1982; 6(4):327-34. PubMed ID: 6752059
[TBL] [Abstract][Full Text] [Related]
14. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
[TBL] [Abstract][Full Text] [Related]
15. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
[TBL] [Abstract][Full Text] [Related]
16. Effects of cyclic somatostatin on insulin, C-peptide and immunoreactive glucagon response to oral glucose loading in obese patients.
Papalia D; Trovato G; Maugeri D; Tribulato A; Lunetta M
Int J Obes; 1982; 6(1):113-20. PubMed ID: 6121763
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of the radioimmunological determination of C-peptide (author's transl)].
Dudczak R; Waldhäusl W
Wien Klin Wochenschr; 1979 Oct; 91(19):658-62. PubMed ID: 120077
[TBL] [Abstract][Full Text] [Related]
18. Insulin, C-peptide, androgens, and beta-endorphin response to oral glucose in patients with polycystic ovary syndrome.
Tropeano G; Lucisano A; Liberale I; Barini A; Vuolo IP; Martino G; Menini E; Dell'Acqua S
J Clin Endocrinol Metab; 1994 Feb; 78(2):305-9. PubMed ID: 8106616
[TBL] [Abstract][Full Text] [Related]
19. [Concentration of C-peptide and insulin in serum of patients with acute virus hepatitis (author's transl)].
Bottermann P; Zilker T; Ermler R; Paterek K; von Stransky B
Klin Wochenschr; 1978 Oct; 56(20):1029-32. PubMed ID: 364178
[TBL] [Abstract][Full Text] [Related]
20. Lack of insulin inhibition on insulin secretion in non-diabetic morbidly obese patients.
Muscelli E; Pereira JA; Lazarin MA; da Silva CA; Pareja JC; Saad MJ
Int J Obes Relat Metab Disord; 2001 Jun; 25(6):798-804. PubMed ID: 11439292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
